Home > Press > Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
Abstract:
Altogen Biosystems
(http://www.altogen.com) announced launch of new contract research
services. Located in Las Vegas, NV, Altogen Custom Services focus on
providing specialized biotechnology and pharmaceutical services, including
RNA Interference (RNAi) services, generation of stably-expressing cell
lines, assay development, screening and transfection services. In
particular, the company will draw upon their unique experience with over
hundred cancer cell lines and expertise in polymer and nanoparticle-based
gene delivery technologies.
Generation of stably-expressing cancer cell lines and primary cells can
be very expensive and time-consuming. Utilizing this method, investigators
are able to develop cells that permanently express specific genes through
their incorporation in the cellular genome. Altogen Custom Services offers
generation of stable cell lines by transforming the cell line of choice to
stably express vector or gene of interest. Optional cloning and shRNA
expression services are available. The service turnaround time is typically
3-4 weeks.
Altogen laboratory research services
(www.altogen.com/support.htm) include:
-- Transfection services (transient and stable)
-- Assay development and library screening
-- Cloning and plasmid vector construction
-- Generation of stable cell lines
-- RNAi experiments (siRNA design, synthesis, validation)
-- Gene targeting (mRNA knockdown, shRNA overexpression)
-- Custom services
####
About Altogen Biosystems
Altogen Biosystems is a life sciences company dedicated to the
development, marketing and manufacture of In Vivo and In Vitro transfection
reagents for intracellular and tissue-targeted delivery of biomolecules.
Altogen Custom Services is a laboratory contract research organization. It
provides specialized contract research to pharmaceutical, biotechnology,
and other life science organizations worldwide.
For more information, please click here
Contacts:
Altogen Biosystems
848 Rainbow Blvd #823
Las Vegas, NV 89107 USA
Tel/Fax: 1-702-989-0841
Customer Support:
1-800-658-7009
Fax: (702) 989-0841
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||